The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial
- PMID: 33382352
- PMCID: PMC7781624
- DOI: 10.1080/19490976.2020.1863133
The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial
Abstract
Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10-3) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = -0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = -0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient.
Keywords: Dietary intervention; Fibre; Gut microbiota; Omega 3; Prebiotic.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7781624/bin/KGMI_A_1863133_F0001_OC.gif)
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7781624/bin/KGMI_A_1863133_F0001_OC.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7781624/bin/KGMI_A_1863133_F0002_OC.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7781624/bin/KGMI_A_1863133_F0002_OC.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7781624/bin/KGMI_A_1863133_F0003_OC.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7781624/bin/KGMI_A_1863133_F0003_OC.gif)
Similar articles
-
Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study.Br J Nutr. 2018 Jan;119(2):176-189. doi: 10.1017/S0007114517003440. Epub 2018 Jan 8. Br J Nutr. 2018. PMID: 29307330 Clinical Trial.
-
Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels.Gut Microbes. 2019;10(3):334-357. doi: 10.1080/19490976.2018.1526583. Epub 2018 Nov 5. Gut Microbes. 2019. PMID: 30395776 Free PMC article.
-
Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.World J Gastroenterol. 2019 Oct 28;25(40):6129-6144. doi: 10.3748/wjg.v25.i40.6129. World J Gastroenterol. 2019. PMID: 31686768 Free PMC article. Clinical Trial.
-
Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review.Crit Rev Food Sci Nutr. 2023;63(7):862-872. doi: 10.1080/10408398.2021.1955654. Epub 2021 Jul 22. Crit Rev Food Sci Nutr. 2023. PMID: 34292103 Review.
-
Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:64-68. doi: 10.1111/jgh.13700. J Gastroenterol Hepatol. 2017. PMID: 28244671 Review.
Cited by
-
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids.Nat Commun. 2024 Apr 23;15(1):3431. doi: 10.1038/s41467-024-45332-w. Nat Commun. 2024. PMID: 38654015 Free PMC article.
-
The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota-Gut-Brain Axis: A Literature Review.Nutrients. 2024 Apr 4;16(7):1054. doi: 10.3390/nu16071054. Nutrients. 2024. PMID: 38613087 Free PMC article. Review.
-
Diet, lifestyle and gut microbiota composition among Malaysian women with gestational diabetes mellitus: a prospective cohort study.Sci Rep. 2024 Mar 22;14(1):6891. doi: 10.1038/s41598-024-57627-5. Sci Rep. 2024. PMID: 38519592 Free PMC article.
-
Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice.Nutrients. 2024 Feb 29;16(5):694. doi: 10.3390/nu16050694. Nutrients. 2024. PMID: 38474822 Free PMC article.
-
Revisiting multi-omics-based predictors of the plasma triglyceride response to an omega-3 fatty acid supplementation.Front Nutr. 2024 Feb 13;11:1327863. doi: 10.3389/fnut.2024.1327863. eCollection 2024. Front Nutr. 2024. PMID: 38414488 Free PMC article.
References
-
- Donovan SM. Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health. Gut Microbes. 2017. March 4;8(2):75–81. doi:10.1080/19490976.2017.1299309. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous